<DOC>
	<DOCNO>NCT02296164</DOCNO>
	<brief_summary>The Valchlor PROVe study multi-center , prospective , observational , US-based drug study longitudinally follow patient MF-CTCL receive therapy Valchlor . Patients follow prospectively maximum 1 year date sign informed consent ( enrollment ) end study . Continuation study contingent continuation Valchlor .</brief_summary>
	<brief_title>Clinical Study Assessing Outcomes , Adverse Events , Treatment Patterns , Quality Life Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma</brief_title>
	<detailed_description>This multi-center , prospective , observational , US-based drug study . All consecutive MF-CTCL patient treat Valchlor invite enroll study.Patients undergo clinical assessment receive standard medical care , determine patient ' physician , real world set . With exception protocol-required patient complete questionnaire symptom QOL , specific mandate clinical assessment perform . Patients follow prospectively maximum 1 year</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Mechlorethamine</mesh_term>
	<criteria>All adult patient ( ≥ 18 year age ) diagnose MF CTCL treat Valchlor . This include patient newly initiate Valchlor OR patient continue treatment Valchlor : Patients newly initiate Valchlor patient first office visit initiate Valchlor . Patients continue treatment Valchlor include patient actively take Valchlor day enrollment . Signed patient inform consent . • None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>PROVe</keyword>
	<keyword>CTCL</keyword>
	<keyword>Mechlorethamine</keyword>
	<keyword>Cutaneous T-cell lymphoma</keyword>
	<keyword>Mycosis fungoides cutaneous T-cell lymphoma</keyword>
	<keyword>Valchlor</keyword>
	<keyword>Dermatology</keyword>
	<keyword>MF-CTCL</keyword>
	<keyword>Mycosis Fungoides</keyword>
	<keyword>Oncology</keyword>
</DOC>